Penicillin Allergy in Shfayim Clinic
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03499457|
Recruitment Status : Unknown
Verified April 2018 by Dr. Lital Goldberg, Clalit Health Services.
Recruitment status was: Not yet recruiting
First Posted : April 17, 2018
Last Update Posted : April 17, 2018
|Condition or disease||Intervention/treatment||Phase|
|Penicillin Allergy||Drug: Amoxicillin||Not Applicable|
issuing a list of patients with a title of penicillin allergy in their medical record. inviting these patients to an appointmnet with their family physician, in which a specific history will be take to evaluate the quality of the allergy.
patients with suscpition of a life threatening allergic reaction will be reffered to an allergy clinic for the challange test. the rest of the pateints will be given the test in the primary clinic: 1ml (50 grams) of amoxicillin, and an hour later a full dose of 500 mg amoxicillin.
after determining no allergic reaction develops the title will be erased from the medical record.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||100 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Penicillin Allergy in Shfayim Clinic|
|Estimated Study Start Date :||June 2018|
|Estimated Primary Completion Date :||January 2019|
|Estimated Study Completion Date :||June 2019|
penicillin chalange test, as descibed.
chalange test of 50 mg, and after an hour 500 mg
- immidiate urticarial reaction [ Time Frame: with 2 hours of test ]shortness of breath, angioedema
- rash [ Time Frame: with 2 hours of test ]body rash or itch seen by patient or physician
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03499457
|Contact: lital f goldberg, MD. MPH.||email@example.com|
|Principal Investigator:||lital f goldberg, MD. MPH||Clalit Health Services|